- Home
- MTEK vs XAIR Comparison
MTEK vs XAIR Comparison
Compare MTEK & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MTEK | XAIR |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6M | 10.5M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | MTEK | XAIR |
|---|---|---|
| Price | $1.67 | $1.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 88.0K | ★ 22.1M |
| Earning Date | 09-26-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,375,716.00 | ★ $5,802,000.00 |
| Revenue This Year | N/A | $127.85 |
| Revenue Next Year | N/A | $179.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 147.74 |
| 52 Week Low | $1.03 | $0.67 |
| 52 Week High | $4.27 | $10.40 |
Technical Indicators
Market Signals| Indicator | MTEK | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 64.42 | 50.01 |
| Support Level | $1.51 | $1.43 |
| Resistance Level | $1.89 | $2.26 |
| Average True Range (ATR) | 0.14 | 0.32 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 65.74 | 30.85 |
Price Performance
Historical ComparisonAbout MTEK Maris-Tech Ltd.
Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.